Idenix Pharmaceuticals (IDIX)
Idenix Pharmaceuticals Beneish M-Score: -1.912
View IDIX Beneish M-Score with YCharts Pro.
Access these YCharts Pro features:
Export any data you want
Save any chart as an image
Utilize advanced screener power
View 30 years of financial history
over 90 advanced calculations
Enjoy an advertising free experience
IDIX Beneish M-Score Rankings
| Overall | 13th percentile | 3259 of 3761 |
| Sector | 17th percentile | 281 of 342 in Healthcare |
| Industry | 31st percentile | 40 of 58 in Biotechnology |
IDIX Beneish M-Score Range, Past 5 Years
| Minimum | -5.453 | Dec 2010 |
| Maximum | -0.8844 | Dec 2007 |
| Average | -2.969 |
About Beneish M Score
The Beneish M Score helps to uncover companies who are likely to be manipulating their reported earnings. Companies with a higher score are more likely to be manipulators. This is a probabilistic model, so it will not detect manipulators with 100% accuracy.
The best cut-off point depends on the costs mistakenly classifying in one of two ways:
1) Classifying firm that is manipulating earnings as a non-manipulator (Type I error), and
2) Classifying a firm as a manipulator when it actually was not manipulating (Type II Error).
Here are optimal cut-offs according to Beneish, presented as the score followed by the cost of Type I error relative to cost of Type II error):
M Score HTML Table:
| Score | Relative Error Costs (Type I:Type II) |
|---|---|
| M Score > -1.49 | (10:1) | M Score > -1.78 | (20:1) | M Score > -1.89 | (40+:1) |
Beneish excluded financial institutions from his sample when calculating the M-Score, so extreme care should be taken when looking at M-Scores of financial firms - their business models are different from the manufacturing and other service firms that Beneish used in his study.
If you want more details, here is the original Beneish M Score Paper, or you can learn about our calculation by clicking "Learn More" below.
Learn More
You may also be interested in these IDIX related companies
IDIX News
$IDIX looks like the 12.5 17.5 spread is due 2 possible $6/share bump if $GILD settles on Hep. C drug...interesting
about 12 hours ago by johnkelly
about 12 hours ago by johnkelly
$IDIX http://stks.co/40Ve Price broke through the falling trendline from January and strong resistance at 9.50.
about 21 hours ago by BuyOnStrength
about 21 hours ago by BuyOnStrength
$IDIX http://stks.co/40Vb Price bounced from two long-term trendlines forming an interim bottom.
about 21 hours ago by BuyOnStrength
about 21 hours ago by BuyOnStrength
@johnkelly $IDIX Montruous activity today as well, something is going on.
about 4 days ago by littleguy
about 4 days ago by littleguy
thu $IDIX hype seemz 2 have reeturned. huge call volume on OTM callz yesterday. pickin up sum ITMs 2day
about 5 days ago by johnkelly
about 5 days ago by johnkelly
$IDIX HighGrowthFinancial told me a few weeks ago after it hit 9.35 and went back to 785ish that the chart looked good and dont worry.
about 5 days ago by GArgondizza
about 5 days ago by GArgondizza
$IDIX Option Bulls Take Another Shot on Idenix. Pete Najarian. http://stks.co/3zAL
about 5 days ago by littleguy
about 5 days ago by littleguy
$IDIX Any buyout talk? I'd like to hit the INHX, Pharmasset, Idenix trifecta. Nobody likes Hep C more than me
about 5 days ago by Grossgrossgross
about 5 days ago by Grossgrossgross
$IDIX where is EXP. yeah. Calls expired worthless a while ago but long 3000 shares in the 11's
about 5 days ago by PeruvianKnightmare
about 5 days ago by PeruvianKnightmare
$IDIX still marching, spending more confirmation time on da BULLS side
about 5 days ago by HighGrowthFinancial
about 5 days ago by HighGrowthFinancial
Brean Murray Sees Recent Upside in Idenix (IDIX) Related to Possible Gilead (GILD) Settlement in June
May 24, 5:14PM Street Insider
May 24, 5:14PM Street Insider
@GArgondizza @johnkelly Why the love affair with $IDIX today? Don't see any news pending.
about 5 days ago by PattyA_F
about 5 days ago by PattyA_F
$IDIX Getting a bit extended! Be careful, stay disciplined! http://chart.ly/veumy3r
about 5 days ago by TeejTime2
about 5 days ago by TeejTime2
Idenix Pharmaceuticals' CEO Presents at Deutsche Bank 37th Annual Healthcare Conference (Transcript)
May 07, 7:46PM Seeking Alpha
May 07, 7:46PM Seeking Alpha
Idenix Pharmaceuticals Reports First Quarter 2012 Financial Results and HCV Development Program Progress
May 02, 4:05PM GlobeNewswire
May 02, 4:05PM GlobeNewswire
Idenix Pharma (IDIX) Rips, Reports Encouraging Data from IDX719 Phase I
Apr 19, 9:21AM Street Insider
Apr 19, 9:21AM Street Insider
Idenix Pharmaceuticals Provides Update on Hepatitis C Clinical Development Programs
Apr 19, 7:53AM Benzinga
Apr 19, 7:53AM Benzinga
Credit Suisse Assumes Coverage on Idenix Pharmaceuticals Inc. (IDIX) at Neutral
Apr 17, 7:47AM Street Insider
Apr 17, 7:47AM Street Insider
Recent Quotes
| Symbol | Price | Chg | Chg % | Market Cap |
|---|---|---|---|---|
| IDIX | 9.41 | -0.27 | -2.79% | 1.041B |
| IDI | 1.85 | -0.03 | -1.60% | 38.59M |
| IDCC | 25.28 | +0.14 | +0.56% | 1.134B |
| IDA | 39.30 | +0.17 | +0.43% | 1.955B |
| ICUI | 52.22 | +0.21 | +0.40% | 722.94M |
| ICS | 15.36 | +0.07 | +0.46% | |
| ICON | 15.86 | +0.38 | +2.45% | 1.123B |
| ICLR | 21.90 | -0.03 | -0.14% | 1.319B |
| ICH | 4.11 | -0.05 | -1.20% | 29.91M |
| ICGE | 8.82 | +0.03 | +0.34% | 329.98M |
